147 related articles for article (PubMed ID: 27230709)
1. Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study.
Obermair A; Youlden D; Baade P; Janda M
Asia Pac J Clin Oncol; 2017 Feb; 13(1):68-78. PubMed ID: 27230709
[TBL] [Abstract][Full Text] [Related]
2. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.
Obermair A; Youlden DR; Baade PD; Janda M
Int J Cancer; 2014 May; 134(9):2211-22. PubMed ID: 24127248
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
Schmeler KM; Sun CC; Bodurka DC; White KG; Soliman PT; Uyei AR; Erlichman JL; Arun BK; Daniels MS; Rimes SA; Peterson SK; Slomovitz BM; Milam MR; Gershenson DM; Lu KH
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):515-20. PubMed ID: 16946209
[TBL] [Abstract][Full Text] [Related]
5. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality.
Tuesley KM; Protani MM; Webb PM; Dixon-Suen SC; Wilson LF; Stewart LM; Jordan SJ
Am J Obstet Gynecol; 2020 Nov; 223(5):723.e1-723.e16. PubMed ID: 32376318
[TBL] [Abstract][Full Text] [Related]
6. Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.
Evans EC; Matteson KA; Orejuela FJ; Alperin M; Balk EM; El-Nashar S; Gleason JL; Grimes C; Jeppson P; Mathews C; Wheeler TL; Murphy M;
Obstet Gynecol; 2016 Sep; 128(3):476-85. PubMed ID: 27500347
[TBL] [Abstract][Full Text] [Related]
7. Potential adverse effects of prophylactic bilateral salpingo-oophorectomy on skin aging in premenopausal women undergoing hysterectomy for benign conditions.
Töz E; Özcan A; Balsak D; Avc ME; Eraslan AG; Balc DD
Menopause; 2016 Feb; 23(2):138-42. PubMed ID: 26382316
[TBL] [Abstract][Full Text] [Related]
8. Determinants of the decision to perform prophylactic oophorectomy in association with a hysterectomy for a benign condition.
Plusquin C; Fastrez M; Vandromme J; Rozenberg S
Maturitas; 2012 Oct; 73(2):164-6. PubMed ID: 22964073
[TBL] [Abstract][Full Text] [Related]
9. Timing of prophylactic hysterectomy-oophorectomy, mastectomy, and microsurgical breast reconstruction in BRCA1 and BRCA2 carriers.
Khansa I; Wang D; Coriddi M; Tiwari P
Microsurgery; 2014 May; 34(4):271-6. PubMed ID: 24123194
[TBL] [Abstract][Full Text] [Related]
10. Ovarian removal and subsequent breast cancer prognosis: a nationwide cohort study.
Gottschau M; Kjær SK; Viuff JH; Jensen A; Munk C; Settnes A; Mellemkjær L
Breast Cancer Res Treat; 2023 Feb; 197(3):583-591. PubMed ID: 36482232
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting gynaecologists' decision to perform prophylactic oophorectomy concomitantly with hysterectomy: a Belgian survey.
Plusquin C; Fastrez M; Vandromme J; Rozenberg S
Maturitas; 2011 Dec; 70(4):391-4. PubMed ID: 22014472
[TBL] [Abstract][Full Text] [Related]
12. Premenopausal gynecologic surgery and survival among black and white women with breast cancer.
Roberson ML; Nichols HB; Olshan AF; A Troester M; Robinson WR
Cancer Causes Control; 2020 Feb; 31(2):105-112. PubMed ID: 31828465
[TBL] [Abstract][Full Text] [Related]
13. Hysterectomy and Risk of Breast, Colorectal, Thyroid, and Kidney Cancer - an Australian Data Linkage Study.
Wilson LF; Tuesley KM; Webb PM; Dixon-Suen SC; Stewart LM; Jordan SJ
Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):904-911. PubMed ID: 33619026
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic oophorectomy either with or without hysterectomy for early breast cancer.
Kucera E; Holub Z; Svobodova G
Eur J Gynaecol Oncol; 2007; 28(4):294-6. PubMed ID: 17713096
[TBL] [Abstract][Full Text] [Related]
15. Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications.
Sasse SA; Lee SS; Rajeev P; Sharma SR; Kahan T; Pothuri B
Gynecol Oncol; 2023 Dec; 179():131-137. PubMed ID: 37988946
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer risk after salpingectomy: a nationwide population-based study.
Falconer H; Yin L; Grönberg H; Altman D
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25628372
[TBL] [Abstract][Full Text] [Related]
17. Oophorectomy and hysterectomy and cancer incidence in the Cancer Prevention Study-II Nutrition Cohort.
Gaudet MM; Gapstur SM; Sun J; Teras LR; Campbell PT; Patel AV
Obstet Gynecol; 2014 Jun; 123(6):1247-1255. PubMed ID: 24807324
[TBL] [Abstract][Full Text] [Related]
18. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries.
Ayhan A; Guvenal T; Salman MC; Ozyuncu O; Sakinci M; Basaran M
Gynecol Oncol; 2005 Aug; 98(2):235-41. PubMed ID: 15982725
[TBL] [Abstract][Full Text] [Related]
19. Effects of bilateral salpingo-oophorectomy at the time of hysterectomy on pelvic organ prolapse: results from the Women's Health Initiative trial.
Shveiky D; Kudish BI; Iglesia CB; Park AJ; Sokol AI; Lehman AM; Shara N; Howard BV
Menopause; 2015 May; 22(5):483-8. PubMed ID: 25423323
[TBL] [Abstract][Full Text] [Related]
20. Concomitant Bilateral Salpingo-Oophorectomy at Hysterectomy: Differences by Race and Menopausal Status in the Veterans Affairs Health Care System, 2007-2014.
Bossick AS; Katon JG; Gray KE; Ma EW; Callegari LS
J Womens Health (Larchmt); 2020 Dec; 29(12):1513-1519. PubMed ID: 33095114
[No Abstract] [Full Text] [Related]
[Next] [New Search]